X-ray intraoperative radiation therapy system INTRABEAM 600
breast cancer treeatmentmobile

X-ray intraoperative radiation therapy system
X-ray intraoperative radiation therapy system
X-ray intraoperative radiation therapy system
X-ray intraoperative radiation therapy system
X-ray intraoperative radiation therapy system
X-ray intraoperative radiation therapy system
X-ray intraoperative radiation therapy system
X-ray intraoperative radiation therapy system
X-ray intraoperative radiation therapy system
Add to favorites
Compare this product
 

Characteristics

Type of treatment
X-ray
Applications
breast cancer treeatment
Ergonomics
mobile

Description

The X-ray source (XRS) with different applicator types creates a very focused radiation field. This leads to a targeted local high dose irradiation and enables increased tumor bed sterilization.1 A very low radiation scattering spares healthy structures and organs at risk from radiation reducing unwanted side-effects2 in contrary to conventional treatment workflows. The ZEISS INTRABEAM Spherical Applicator can be used for the intracavitary intraoperative delivery of radiation to the tumor bed, e.g. at the time of breast conserving surgery. The ZEISS INTRABEAM Needle Applicator can be used for the interstitial irradiation of tumors, e.g. in the treatment of vertebral metastases or brain tumors. The ZEISS INTRABEAM Flat Applicator can be used for the treatment of the tumor bed on surgically exposed surfaces, e.g. tumors of the gastrointestinal tract. The ZEISS INTRABEAM Surface Applicator can be used in the treatment of the tumor bed on the surface of the body, for example, irradiation of non-melanoma skin cancers. Immediate irradiation during surgery in the OR prevents tumor reformation stimulated by wound healing after resection3,4 and can lead to shorter overall treatments. This efficiently saves hospital time without compromising outcomes and lets patients benefit from a completed treatment while sleeping Post-operative treatment times of up to 6.5 weeks can be reduced to 3-5 weeks or even be eliminated for selected patients when adding IORT during breast-conserving surgery (BCS).

Catalogs

No catalogs are available for this product.

See all of ZEISS Medical Technology‘s catalogs

Exhibitions

Meet this supplier at the following exhibition(s):

ANALYTICA 2024
ANALYTICA 2024

9-12 Apr 2024 München (Germany) Hall A2.508 - Stand Vide

  • More information
    *Prices are pre-tax. They exclude delivery charges and customs duties and do not include additional charges for installation or activation options. Prices are indicative only and may vary by country, with changes to the cost of raw materials and exchange rates.